Bonus & Incentive Agreements in the Pharmaceuticals Industry

2,392 Contracts & Agreements

Browse by Company

60 DEGREES PHARMACEUTICALS, INC. (2 contracts)
Acasti Pharma Inc. (2)
ACELRX PHARMACEUTICALS INC (20)
Acer Therapeutics Inc. (10)
ACHILLION PHARMACEUTICALS INC (7)
Aclaris Therapeutics, Inc. (5)
Acreage Holdings, Inc. (4)
ACURA PHARMACEUTICALS, INC (2)
Adamis Pharmaceuticals Corp (14)
ADIAL PHARMACEUTICALS, INC. (9)
Aegerion Pharmaceuticals, Inc. (6)
AEON Biopharma, Inc. (6)
AERIE PHARMACEUTICALS INC (6)
Aerpio Pharmaceuticals, Inc. (11)
AGILE THERAPEUTICS INC (5)
Akers Biosciences, Inc. (9)
Akorn (6)
ALDER BIOPHARMACEUTICALS INC (9)
Alexza Pharmaceuticals Inc. (9)
ALGORX PHARMACEUTICALS INC (1)
ALIMERA SCIENCES INC (18)
Allergan, plc (9)
ALSERES PHARMACEUTICALS INC (2)
Altus Pharmaceuticals Inc. (3)
Amag Pharmaceuticals (20)
Amneal Pharmaceuticals, Inc. (6)
Amphastar Pharma (4)
Ampio Pharmaceuticals, Inc. (4)
AMYLIN PHARMACEUTICALS INC (7)
Amylyx Pharmaceuticals, Inc. (3)
AN2 Therapeutics, Inc. (5)
Anacor Pharmaceuticals, Inc. (9)
Anebulo Pharmaceuticals, Inc. (2)
Angion Biomedica Corp. (11)
ANI Pharma Inc (24)
Anthera Pharmaceuticals Inc (7)
Apimeds Pharmaceuticals US, Inc. (1)
APP Pharmaceuticals, Inc. (1)
APRICUS BIOSCIENCES, INC. (4)
Aquestive Therapeutics, Inc. (5)
Aralez Pharmaceuticals Inc. (11)
ARIAD PHARMACEUTICALS INC (11)
Arog Pharmaceuticals, Inc. (1)
ARTELO BIOSCIENCES, INC. (2)
ARVINAS, INC. (7)
Assertio Holdings, Inc. (5)
Assertio Therapeutics, Inc (22)
ATAI Life Sciences B.V. (6)
Atea Pharmaceuticals, Inc. (6)
Athira Pharma, Inc. (9)
Auspex Pharmaceuticals, Inc. (6)
AUXILIUM PHARMACEUTICALS INC (5)
AVADEL PHARMACEUTICALS PLC (3)
AVALON PHARMACEUTICALS INC (4)
AVANIR PHARMACEUTICALS, INC. (7)
AVENUE THERAPEUTICS, INC. (2)
Axsome Therapeutics, Inc. (7)
AYTU BIOSCIENCE, INC (1)
Bakhu Holdings, Corp. (1)
Baudax Bio, Inc. (2)
Bausch Health Companies Inc. (27)
BENTLEY PHARMACEUTICALS INC (5)
Bespoke Extracts, Inc. (1)
Big Rock Partners Acquisition Corp. (1)
BIODELIVERY SCIENCES INTERNATIONAL INC (14)
Biofrontera Inc. (6)
Biohaven Ltd. (1)
BioPharmX Corp (5)
Blue Water Acquisition Corp. (2)
Braeburn Pharmaceuticals, Inc. (1)
Bristol-Myers Squibb (112)
CADENCE PHARMACEUTICALS INC (10)
Cancer Prevention Pharmaceuticals, Inc. (6)
Cannabics Pharmaceuticals Inc. (1)
Canopy Growth Corp (9)
Cara Therapeutics, Inc. (4)
CARDAX, INC. (1)
CASSAVA SCIENCES INC (10)
Catalent Inc (42)
Celator Pharmaceuticals Inc (1)
CELGENE CORP (15)
CERAGENIX PHARMACEUTICALS, INC. (1)
Cerecor Inc. (6)
Charlotte's Web Holdings, Inc. (1)
CHIASMA, INC (2)
CHINA PHARMA HOLDINGS, INC. (3)
CinCor Pharma, Inc. (1)
Cingulate Inc. (4)
Citius Pharmaceuticals, Inc. (3)
Clearside Biomedical, Inc. (7)
Clever Leaves Holdings Inc. (6)
CLS Holdings USA, Inc. (2)
Cocrystal Pharma, Inc. (1)
COGNITION THERAPEUTICS INC (7)
COLLEGIUM PHARMACEUTICAL, INC (14)
CoLucid Pharmaceuticals, Inc. (7)
Columbia Care Inc. (2)
Context Therapeutics Inc. (3)
Corcept Therapeutics Incorporated (6)
CorMedix Inc. (6)
COSMO VENTURES INC (1)
CPEX Pharmaceuticals, Inc. (1)
Cronos Group Inc. (3)
CUBIST PHARMACEUTICALS INC (29)
CUMBERLAND PHARMACEUTICALS INC (10)
Cure Pharmaceutical Holding Corp. (4)
CymaBay Therapeutics, Inc. (4)
Cyteir Therapeutics, Inc. (9)
Dermata Therapeutics, Inc. (6)
DiCE MOLECULES HOLDINGS, LLC (2)
Dova Pharmaceuticals Inc. (4)
EASTON PHARMACEUTICALS INC. (1)
Edgewise Therapeutics, Inc. (4)
Egalet Corp (12)
Elanco Animal Health Inc (9)
ELITE PHARMACEUTICALS INC (1)
Elixir Pharmaceuticals, Inc. (5)
Eloxx Pharmaceuticals, Inc. (10)
ENCYSIVE PHARMACEUTICALS INC (1)
Endo International plc (39)
Endo Pharmaceuticals Solutions Inc. (4)
EPIX Pharmaceuticals, Inc. (6)
Eton Pharmaceuticals, Inc. (6)
Evofem Biosciences, Inc. (13)
Evoke Pharma Inc (5)
Evolus, Inc. (7)
Exactus, Inc. (7)
EYEGATE PHARMACEUTICALS INC (8)
EYENOVIA, INC. (6)
EyePoint Pharmaceuticals, Inc. (25)
EYETECH PHARMACEUTICALS INC (2)
Foamix Pharmaceuticals Ltd. (3)
Fulcrum Therapeutics, Inc. (11)
GB SCIENCES INC (1)
GENAISSANCE PHARMACEUTICALS INC (2)
GRAYBUG VISION, INC. (4)
Green Thumb Industries Inc. (3)
GUILFORD PHARMACEUTICALS INC (2)
GW PHARMACEUTICALS PLC (2)
Harmony Biosciences Holdings, Inc. (7)
HARROW HEALTH, INC. (11)
Horizon Pharma plc (13)
Hoth Therapeutics, Inc. (1)
IDENIX PHARMACEUTICALS INC (8)
Ikena Oncology, Inc. (2)
IMARA Inc. (12)
INNOVATE BIOPHARMACEUTICALS, INC. (12)
Innoviva, Inc. (33)
INSPIRE PHARMACEUTICALS INC (5)
Intersect ENT, Inc. (10)
Intra-Cellular Therapies, Inc. (16)
ISTA PHARMACEUTICALS INC (3)
Iterum Therapeutics plc (11)
Jaguar Health, Inc. (5)
JAVELIN PHARMACEUTICALS, INC (2)
Jazz Pharmaceuticals plc (66)
Johnson & Johnson (9)
Journey Medical Corp (1)
JUNIPER PHARMACEUTICALS INC (9)
Jushi Holdings Inc. (2)
Kala Pharmaceuticals, Inc. (12)
Kaleido Biosciences, Inc. (3)
Kannalife Inc (2)
Kaya Holdings, Inc. (1)
KEMPHARM, INC (4)
KING PHARMACEUTICALS INC (19)
KOLLTAN PHARMACEUTICALS INC (3)
KOS PHARMACEUTICALS INC (1)
Landos Biopharma, Inc. (1)
Lannett Company, Inc. (1)
Lexaria Bioscience Corp. (1)
Lilly (Eli) & Co. (23)
LIPELLA PHARMACEUTICALS INC (7)
Lipocine Inc. (5)
Liquidia Corp (9)
Liquidia Technologies Inc (1)
Longboard Pharmaceuticals, Inc. (9)
Lowell Farms Inc. (1)
Lumena Pharmaceuticals, Inc. (1)
Lyra Therapeutics, Inc. (7)
Mallinckrodt (38)
MAP Pharmaceuticals, Inc. (2)
Marijuana Co of America, Inc. (1)
MARINUS PHARMACEUTICALS INC (17)
Medicine Man Technologies, Inc. (8)
MedMen Enterprises, Inc. (1)
Melt Pharmaceuticals, Inc. (5)
MEMORY PHARMACEUTICALS CORP (1)
Menlo Therapeutics Inc. (16)
Merck (69)
MiddleBrook Pharmaceuticals, Inc. (1)
Milestone Pharmaceuticals Inc. (6)
MILLENNIUM PHARMACEUTICALS INC (2)
Mind Medicine (MindMed) Inc. (2)
MIRA PHARMACEUTICALS, INC. (2)
Molecular Insight Pharmaceuticals, Inc. (2)
Mylan N.V. (17)
MYnd Analytics, Inc. (3)
MyoKardia Inc (4)
Nabriva Therapeutics plc (13)
NEKTAR THERAPEUTICS (24)
Neos Therapeutics, Inc. (2)
Neuralstem, Inc. (11)
NEW RIVER PHARMACEUTICALS INC (1)
NEXIEN BIOPHARMA, INC. (2)
NGM BIOPHARMACEUTICALS INC (5)
NovaBay Pharmaceuticals, Inc. (8)
Novan, Inc. (7)
NPS PHARMACEUTICALS INC (7)
NUCRYST Pharmaceuticals Corp. (4)
OCULAR THERAPEUTIX, INC (13)
OMEROS CORP (4)
Omthera Pharmaceuticals, Inc. (2)
OncoMed Pharmaceuticals Inc (6)
Onconova Therapeutics, Inc. (4)
One World Pharma, Inc. (3)
ONYX PHARMACEUTICALS INC (12)
OPIANT PHARMACEUTICALS, INC. (6)
OPTIMER PHARMACEUTICALS INC (5)
OptiNose, Inc. (7)
ORAMED PHARMACEUTICALS INC. (4)
Organon & Co. (7)
OSCIENT PHARMACEUTICALS CORP (2)
OSI PHARMACEUTICALS INC (6)
Osmotica Pharmaceuticals plc (9)
OTONOMY, INC. (4)
Pacira Pharmaceuticals, Inc. (14)
Panacea Acquisition Corp (6)
PANACOS PHARMACEUTICALS, INC. (4)
Paratek Pharmaceuticals, Inc. (13)
PaxMedica, Inc. (5)
PEAK PHARMACEUTICALS, INC. (1)
PENWEST PHARMACEUTICALS CO (7)
Perrigo (43)
PetLife Pharmaceuticals, Inc. (1)
Petros Pharmaceuticals, Inc. (3)
Pfizer (10)
Phathom Pharmaceuticals, Inc. (11)
Phibro Animal Health Corporation (3)
PLIANT THERAPEUTICS, INC. (3)
PLx Pharma Inc. (5)
PONIARD PHARMACEUTICALS, INC. (11)
PRAECIS PHARMACEUTICALS INC (1)
PREDIX PHARMACEUTICALS HOLDINGS INC (3)
Prestige Brands Holdings Inc (4)
Processa Pharmaceuticals, Inc. (2)
ProPhase Labs, Inc. (3)
Provention Bio, Inc. (3)
Pulmatrix, Inc. (6)
QUANTA INC (1)
QUARK PHARMACEUTICALS INC (3)
QUATRX PHARMACEUTICALS CO (1)
QUESTCOR PHARMACEUTICALS INC (3)
Ra Pharmaceuticals, Inc. (2)
RADIENT PHARMACEUTICALS Corp (1)
Rain Therapeutics Inc. (9)
Rani Therapeutics Holdings, Inc. (3)
REATA PHARMACEUTICALS INC (3)
Recro Pharma, Inc. (9)
Reliant Pharmaceuticals, Inc. (7)
RELMADA THERAPEUTICS, INC. (11)
RespireRx Pharmaceuticals Inc. (16)
resTORbio, Inc. (20)
Revance Therapeutics, Inc. (21)
Rib-X Pharmaceuticals, Inc. (10)
ROCK CREEK PHARMACEUTICALS, INC. (7)
Roivant Sciences Ltd. (9)
Royalty Pharma plc (2)
Sagent Pharmaceuticals, Inc. (5)
SALIX PHARMACEUTICALS LTD (1)
SANCILIO PHARMACEUTICALS COMPANY, INC. (2)
Satsuma Pharmaceuticals, Inc. (7)
SAVIENT PHARMACEUTICALS INC (4)
SCICLONE PHARMACEUTICALS INC (13)
Scopus BioPharma Inc. (2)
scPharmaceuticals Inc. (3)
SCYNEXIS INC (4)
SenesTech, Inc. (6)
Shuttle Pharmaceuticals, Inc. (1)
Sienna Biopharmaceuticals, Inc. (11)
SIGA TECHNOLOGIES INC (5)
Strongbridge Biopharma plc (1)
Sucampo Pharmaceuticals, Inc. (9)
Supernus Pharmaceuticals, Inc. (13)
SYNERGY PHARMACEUTICALS, INC. (1)
TAPESTRY PHARMACEUTICALS, INC (3)
Targeted Medical Pharma, Inc. (5)
Tarsus Pharmaceuticals, Inc. (2)
Telomir Pharmaceuticals, Inc. (2)
Tenzing Acquisition Corp. (4)
Terns Pharmaceuticals, Inc. (8)
Terra Tech Corp. (7)
TerrAscend Corp. (1)
TETRALOGIC PHARMACEUTICALS CORP (4)
TETRAPHASE PHARMACEUTICALS INC (7)
TEVA PHARMACEUTICAL INDUSTRIES LTD (19)
TFF Pharmaceuticals, Inc. (1)
THAR PHARMACEUTICALS INC (2)
The Medicines Company (16)
TherapeuticsMD, Inc. (2)
Theravance Biopharma, Inc. (9)
Theseus Pharmaceuticals, Inc. (2)
Tilray, Inc. (6)
TILT Holdings Inc. (4)
TITAN PHARMACEUTICALS INC (7)
Trevi Therapeutics, Inc. (4)
Tricida, Inc. (3)
Trulieve Cannabis Corp. (2)
Upjohn Inc (8)
Urigen Pharmaceuticals, Inc. (2)
Urovant Sciences Ltd. (5)
VALEANT PHARMACEUTICALS INTERNATIONAL (2)
Valera Pharmaceuticals Inc (2)
Vallon Pharmaceuticals, Inc. (8)
Ventyx Biosciences, Inc. (4)
Verano Holdings Corp. (4)
Verona Pharma plc (1)
Verrica Pharmaceuticals Inc. (4)
Viamet Pharmaceuticals Holdings LLC (3)
VION PHARMACEUTICALS INC (2)
VioQuest Pharmaceuticals, Inc. (2)
Vireo Health International, Inc. (3)
Virpax Pharmaceuticals, Inc. (8)
Vitae Pharmaceuticals, Inc (4)
Vitality Biopharma, Inc. (4)
VIVUS INC (3)
Wave Life Sciences Ltd. (17)
Winston Pharmaceuticals, Inc. (1)
XANODYNE PHARMACEUTICALS INC (4)
XERIS PHARMACEUTICALS INC (3)
Zoetis (9)
ZOGENIX, INC. (11)
Zynerba Pharmaceuticals, Inc. (12)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

2021 Equity Incentive Plan

Bonus & Incentive Agreements

Panacea Acquisition Corp

Pharmaceuticals

DE

2021

First Amendment to the TNF Pharmaceuticals, Inc. 2021 Equity Incentive Plan

Bonus & Incentive Agreements

Akers Biosciences, Inc.

2024

Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement (Executives and Non-Employee Directors) pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation...

Bonus & Incentive Agreements

Axsome Therapeutics, Inc.

2024

Axsome Therapeutics, Inc. Form of Restricted Stock Unit Agreement (Non-Executives) pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation Plan

Bonus & Incentive Agreements

Axsome Therapeutics, Inc.

2024

Axsome Therapeutics, Inc. Form of Stock Option Agreement pursuant to the Amended and Restated 2015 Omnibus Incentive Compensation Plan

Bonus & Incentive Agreements

Axsome Therapeutics, Inc.

2024

Amendment No. 6 to the Adial Pharmaceuticals, Inc. 2017 Equity Incentive Plan

Bonus & Incentive Agreements

ADIAL PHARMACEUTICALS, INC.

2024

AMENDMENT NO. 3 TO THE GREEN THUMB INDUSTRIES INC. 2018 STOCK AND INCENTIVE PLAN

Bonus & Incentive Agreements

Green Thumb Industries Inc.

2024

ANI Pharmaceuticals, Inc Amended and Restated 2022 Stock Incentive Plan Notice of Restric

Bonus & Incentive Agreements

ANI Pharma Inc

2024

ANI Pharmaceuticals, Inc. Amended and Restated 2022 Stock Incentive Plan Sub-Plan for U.K. Employees

Bonus & Incentive Agreements

ANI Pharma Inc

2024

Acasti Pharma Inc. 2024 Equity Incentive Plan

Bonus & Incentive Agreements

Acasti Pharma Inc.

2024

Apimeds Pharmaceuticals US, Inc. 2024 Equity Incentive Plan

Bonus & Incentive Agreements

Apimeds Pharmaceuticals US, Inc.

2024

Form of Retention Bonus Letter

Bonus & Incentive Agreements

Aerpio Pharmaceuticals, Inc.

2024

CalciMedica, Inc. 2023 Equity Incentive Plan

Bonus & Incentive Agreements

GRAYBUG VISION, INC.

2024

Edgewise Therapeutics, Inc. 2024 Inducement Equity Incentive Plan and related forms of stock option and restricted stock unit agreements

Bonus & Incentive Agreements

Edgewise Therapeutics, Inc.

2024

Wave Life Sciences Ltd. 2021 Equity Incentive Plan, as amended

Bonus & Incentive Agreements

Wave Life Sciences Ltd.

2024

Nektar Therapeutics Amended and Restated 2017 Performance Incentive Plan, as amended

Bonus & Incentive Agreements

NEKTAR THERAPEUTICS

2024

Form of Global Terms for 2024 Restricted Stock Unit Award Under the Organon & Co. 2021 Incentive Stock Plan (Cash Default)

Bonus & Incentive Agreements

Organon & Co.

2024

Form of Global Terms for 2024 Restricted Stock Unit Award Under the Organon & Co. 2021 Incentive Stock Plan (Stock Default)

Bonus & Incentive Agreements

Organon & Co.

2024

Form of Global Terms for 2024 Performance Stock Unit Award Under the Organon & Co. 2021 Incentive Stock Plan

Bonus & Incentive Agreements

Organon & Co.

2024

Form of Global Terms for 2024 Non-Qualified Stock Option Grants Under the Organon & Co. 2021 Incentive Stock Plan

Bonus & Incentive Agreements

Organon & Co.

2024

Mallinckrodt plc Amended and Restated Long-Term Transaction Incentive Plan

Bonus & Incentive Agreements

Mallinckrodt

2024

Form of Amended and Restated Performance Unit Award for Directors under the Mallinckrodt plc 2024 Stock and Incentive Plan

Bonus & Incentive Agreements

Mallinckrodt

2024

Form of Amended and Restated Performance Unit Award for the CEO under the Mallinckrodt plc 2024 Stock and Incentive Plan

Bonus & Incentive Agreements

Mallinckrodt

2024

Form of Amended and Restated Performance Unit Award for Officers under the Mallinckrodt plc 2024 Stock and Incentive Plan

Bonus & Incentive Agreements

Mallinckrodt

2024

Form of Amended and Restated Restricted Unit Award for Directors under the Mallinckrodt plc 2024 Stock and Incentive Plan

Bonus & Incentive Agreements

Mallinckrodt

2024

Form of Amended and Restated Restricted Unit Award for the CEO under the Mallinckrodt plc 2024 Stock and Incentive Plan

Bonus & Incentive Agreements

Mallinckrodt

2024

Form of Amended and Restated Restricted Unit Award for Officers under the Mallinckrodt plc 2024 Stock and Incentive Plan

Bonus & Incentive Agreements

Mallinckrodt

2024

Longboard Pharmaceuticals, Inc. 2021 Equity Incentive Plan (as amended and restated May 23, 2024)

Bonus & Incentive Agreements

Longboard Pharmaceuticals, Inc.

2024

Form of Non-Employee Directors Restricted Stock Unit Grant Agreement under the SIGA Technologies, Inc. 2010 Stock Incentive Plan (amended and restated effective April 18, 2017)

Bonus & Incentive Agreements

SIGA TECHNOLOGIES INC

2024

Form of Performance Stock Unit Grant Agreement under the SIGA Technologies, Inc. 2010 Stock Incentive Plan (amended and restated effective April 18, 2017)

Bonus & Incentive Agreements

SIGA TECHNOLOGIES INC

2024

Form of Restricted Stock Unit Grant Agreement under the SIGA Technologies, Inc. 2010 Stock Incentive Plan (amended and restated effective April 18, 2017)

Bonus & Incentive Agreements

SIGA TECHNOLOGIES INC

2024

Form of Stock Option Grant Agreement under the SIGA Technologies, Inc. 2010 Stock Incentive Plan (amended and restated effective April 18, 2017)

Bonus & Incentive Agreements

SIGA TECHNOLOGIES INC

2024

Amendment to the Virpax Pharmaceuticals, Inc. 2022 Equity Incentive Plan to Increase Evergreen Provision Percentage

Bonus & Incentive Agreements

Virpax Pharmaceuticals, Inc.

2024

Amendment to the Virpax Pharmaceuticals, Inc. 2022 Equity Incentive Plan to Increase in Authorized Shares

Bonus & Incentive Agreements

Virpax Pharmaceuticals, Inc.

2024

SenesTech, Inc. 2018 Equity Incentive Plan, as amended

Bonus & Incentive Agreements

SenesTech, Inc.

2024

Elite Pharmaceuticals, Inc. Restated 2014 Equity Incentive Plan

Bonus & Incentive Agreements

ELITE PHARMACEUTICALS INC

2024

Amendment to the Avenue Therapeutics, Inc. 2015 Incentive Plan

Bonus & Incentive Agreements

AVENUE THERAPEUTICS, INC.

2024

Amendment to the Journey Medical Corporation 2015 Stock Incentive Plan

Bonus & Incentive Agreements

Journey Medical Corp

2024

Amended and Restated 2020 Equity Incentive Plan

Bonus & Incentive Agreements

ACELRX PHARMACEUTICALS INC

2024

EyePoint Pharmaceuticals, Inc. Amendment No 1. to 2023 Long-Term Incentive Plan

Bonus & Incentive Agreements

EyePoint Pharmaceuticals, Inc.

2024

Amended and Restated 2020 Equity Incentive Plan

Bonus & Incentive Agreements

IMARA Inc.

2024